Functionality of In vitro Reconstituted Group II Intron RmInt1-Derived Ribonucleoprotein Particles by Maria D. Molina-Sánchez et al.
ORIGINAL RESEARCH
published: 27 September 2016
doi: 10.3389/fmolb.2016.00058
Frontiers in Molecular Biosciences | www.frontiersin.org 1 September 2016 | Volume 3 | Article 58
Edited by:
Ulf Andersson Ørom,




University of Hyogo, Japan
Sunny Sharma,





This article was submitted to
Ribonucleoprotein Networks,
a section of the journal
Frontiers in Molecular Biosciences
Received: 28 July 2016
Accepted: 12 September 2016
Published: 27 September 2016
Citation:
Molina-Sánchez MD,
García-Rodríguez FM and Toro N
(2016) Functionality of In vitro
Reconstituted Group II Intron
RmInt1-Derived Ribonucleoprotein
Particles. Front. Mol. Biosci. 3:58.
doi: 10.3389/fmolb.2016.00058
Functionality of In vitro Reconstituted
Group II Intron RmInt1-Derived
Ribonucleoprotein Particles
Maria D. Molina-Sánchez, Fernando M. García-Rodríguez and Nicolás Toro*
Structure, Dynamics and Function of Rhizobacterial Genomes, Department of Soil Microbiology and Symbiotic Systems,
Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain
The functional unit of mobile group II introns is a ribonucleoprotein particle (RNP)
consisting of the intron-encoded protein (IEP) and the excised intron RNA. The IEP
has reverse transcriptase activity but also promotes RNA splicing, and the RNA-protein
complex triggers site-specific DNA insertion by reverse splicing, in a process called
retrohoming. In vitro reconstituted ribonucleoprotein complexes from the Lactococcus
lactis group II intron Ll.LtrB, which produce a double strand break, have recently been
studied as a means of developing group II intron-based gene targeting methods for
higher organisms. The Sinorhizobium meliloti group II intron RmInt1 is an efficient mobile
retroelement, the dispersal of which appears to be linked to transient single-stranded
DNA during replication. The RmInt1IEP lacks the endonuclease domain (En) and cannot
cut the bottom strand to generate the 3′ end to initiate reverse transcription. We
used an Escherichia coli expression system to produce soluble and active RmInt1
IEP and reconstituted RNPs with purified components in vitro. The RNPs generated
were functional and reverse-spliced into a single-stranded DNA target. This work
constitutes the starting point for the use of group II introns lacking DNA endonuclease
domain-derived RNPs for highly specific gene targeting methods.
Keywords: catalytic RNAs, ribonucleoprotein particles, intron-encoded protein, maturase, reverse transcriptase,
DNA endonuclease, reverse splicing
INTRODUCTION
Group II introns are mobile genetic retroelements present in the genomes of bacteria and
organelles. They are related to spliceosomal introns, telomerase and retrotransposons in eukaryotes,
and are even considered to have played a key role in the origin of eukaryotic cells and genetic
evolution (Koonin, 2006; Lambowitz and Belfort, 2015). In recent years, they have also been used
in various biotechnological applications in prokaryotes and eukaryotes, due to their ability to
recognize specific sequences for their insertion (Toro et al., 2007; Enyeart et al., 2014). They usually
consist of a catalytically active intron RNA and an intron-encoded protein (IEP) that act together as
a ribonucleoprotein (RNP) particle (Lambowitz et al., 1999; Saldanha et al., 1999; Lambowitz and
Zimmerly, 2004). Immediately after its translation, the IEP is stabilized by binding to the unspliced
precursor RNA, facilitating intron lariat excision by successive transesterifications to generate the
active RNP complex for intron mobility (recently reviewed in Lambowitz and Belfort, 2015). Thus,
the RNP particles can insert the lariat RNA into a short, specific DNA sequence recognized by both
RNA and protein components in the reverse reaction to intron splicing (Guo et al., 1997; Singh
and Lambowitz, 2001; Jiménez-Zurdo et al., 2003). Some RNP enzymes produce a double strand
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break (those with an endonuclease domain, see below) and use
the 3′ end of the bottom strand to initiate reverse transcription
(Zimmerly et al., 1995; Matsuura et al., 1997), but other
complexes cannot cut the bottom strand, and an alternative
method is therefore required for priming during cDNA synthesis
(Muñoz-Adelantado et al., 2003; Martínez-Abarca et al., 2004).
The integration process is completed by host enzymes that
degrade the RNA, synthesize the complementary strand of cDNA
and repair nicks in the DNA (Smith et al., 2005; Coros et al.,
2008, 2009; Yao et al., 2013). As described for HIV-1 RT, RNP
particles were widely thought to be formed by the interaction of
a dimeric protein with a single lariat RNA (Saldanha et al., 1999;
Rambo and Doudna, 2004; Gupta et al., 2014). However, a recent
determination of the structure of RNP particles obtained in vivo
suggested that there was a 1:1 (Qu et al., 2016), or even 2:2 (Zhao
and Pyle, 2016) ratio of protein and RNA in the complex.
The ribozyme has a conserved, complex three-dimensional
structure comprising six domains, DI to DVI (Toor et al., 2008;
Qu et al., 2016). All six domains are important for correct
structure and catalysis, but domain V plays a key role in
nucleating the catalytic residues (the AGC triad and AY bulge)
essential for Mg2+ coordination and in intron activity (Qin and
Pyle, 1998; Gordon and Piccirilli, 2001; Pyle, 2010). The IEP is a
multifunctional protein encoded by domain IV in most bacterial
introns and about half the known organellar group II introns
(Belfort et al., 2002; Lambowitz and Zimmerly, 2011). All these
proteins have an N-terminal reverse transcriptase domain (RT)
followed by a region involved in RNA splicing (domain X or
maturase). Some IEPs also have a DNA binding (D) domain and
a C-terminal DNA endonuclease (En) domain. These domains
have been extensively characterized in LtrA (the IEP encoded by
the L.lactis group II intron Ll.LtrB) (San Filippo and Lambowitz,
2002). The RT domain consists of eight (RT 0–7) to twelve
(RT 2a, 3a, 4a, and 7a) conserved amino-acid blocks resembling
those of telomerase, non-LTR-retrotransposon and retroviral RTs
(Blocker et al., 2005; Zhao and Pyle, 2016). Mutational screening
and unigenic evolution analyses revealed that theN-terminal RT0
region bound the DIVa subdomain of the ribozyme with high
affinity, enabling the protein to regulate its own transcription
(Wank et al., 1999; Singh et al., 2002; Cui et al., 2004; Gu et al.,
2010). Additional contacts involving other RT and maturase
residues seem to be established with the catalytic core of the
excised intron RNA (involving DI, DII, and DVI) and are
required for the formation of fully functional RNP complexes
(Cui et al., 2004; Dai et al., 2008; Qu et al., 2016). The active site
of the RT, the YADD motif in RT5, is not required for intron
splicing or DNA endonuclease activity (Moran et al., 1995; Cui
et al., 2004). By contrast, domain X has been shown to facilitate
the excision of the ribozyme in an intron-specific manner (Mohr
et al., 1993; Moran et al., 1994; Saldanha et al., 1999). Maturase
binding to partially folded introns has been shown to stabilize
tertiary interactions in the RNA, leaving other regions relatively
flexible for productive conformational changes during catalysis
(Matsuura et al., 2001; Noah and Lambowitz, 2003). The D and
En domains are required for intron mobility, due to their role in
DNA target site binding and cleavage during reverse splicing. The
D domain is involved in target DNA recognition, whereas the En
domain, an Mg2+-dependent DNA endonuclease of the H-N-H
family, cleaves the target DNA strand to generate the primer for
reverse transcription (San Filippo and Lambowitz, 2002).
However, a large group of introns lack the D/En domains
(Toro and Martínez-Abarca, 2013), instead having a short
C-terminal extension (Molina-Sánchez et al., 2010). The RTs
of these introns thus have no DNA endonuclease activity and
cannot cut the bottom strand. RmInt1 is the most widely studied
retroelement of this type of group II introns (Martínez-Abarca
et al., 2000). Despite lacking the D and En domains, RmInt1 is
an efficient mobile element, the dispersal of which appears to
be linked to the transient single-stranded DNA formed during
replication (Martínez-Abarca et al., 2004). RmInt1 has been
shown to self-splice under non-physiological conditions in vitro
(Costa et al., 2006; Chillón et al., 2014), and to form an intron
lariat and circles in vivo (Molina-Sánchez et al., 2006). Two
mobility pathways, differing in terms of the priming of reverse
transcription, have been postulated for RmInt1. The preferred
pathway involves the invasion of single-stranded DNA by the
intron, with the nascent lagging DNA strand used as the primer
for intronic cDNA synthesis. A less efficient alternative pathway
has also been suggested, in which the intron probably uses
random non-specific opposite strand nicks, a nascent leading
strand or the de novo initiation of cDNA synthesis.
We show here that the RmInt1 IEP can be readily purified
from Escherichia coli cells, as a highly soluble fusion protein
that is stable and functional in the absence of the intron RNA.
The IEP was competent to assist in accurate lariat excision from
the precursor intron RNA. Similarly, the intron RNA formed
functional RNP particles upon incubation with the purified
fusion protein, directing target DNA cleavage and further reverse
splicing of the intron lariat into DNA substrates.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Sinorhizobium meliloti RMO17 was used for mobility assays. It
was grown at 28◦C on TY or defined minimal medium (Villadas
et al., 1995) supplemented with 180 µg·ml−1 kanamycin and
10 µg·ml−1 tetracycline. E. coli DH5α cells were routinely
cultured at 37◦C in LB medium for molecular cloning. When
required, antibiotics were used at the following concentrations:
180 µg·ml−1 for kanamycin and 200 µg·ml−1 for ampicillin. IEP
were expressed in E. coli Rosetta-gami (DE3): pLysS (Novagen).
This strain was grown at 37◦C in LB medium supplemented
with 0.2% glucose, 100 µg·ml−1 ampicillin, and 50 µg·ml−1
chloramphenicol, with protein induction by incubation with 0.3
mM IPTG at 20◦C for 16–22 h.
Plasmid Constructs
pMALFlagIEP encodes the IEP tagged with 3xFlag fused
to the maltose-binding protein (MBP). This plasmid was
constructed by inserting a NotI fragment containing the FlagIEP
from pCEP4FlagIEP (Reinoso-Colacio et al., 2015) into the
pMAL-c5X vector (New England Biolabs) digested with NotI
and dephosphorylated. pMALFlagIEP mutant constructs were
generated by replacing the C-terminal region of the IEP with the
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corresponding mutated fragment. PCR products containing the
various IEP mutations were obtained with Phusion polymerase
(Thermo Scientific), the primers 21.0 5′-AGAAAAGACGTC
AAATGCAA-3′ and SacBbr 5′-GGGAGCTCACGTGCCTCG
TTTTCATCGATGAGA-3′, and template plasmids containing
the mutated IEP: pKG4-YAHH (Molina-Sánchez et al., 2011);
pKG4-K381 and pKG4A354A355 (Molina-Sánchez et al., 2010).
These PCR fragments were digested with KpnI and PmlI and
inserted into the KpnI/EcoRV-digested pMALFlagIEP.
pLMWT, which was used for in vitro transcription of the
intron precursor, was described in a previous study by Chillón
et al. (2014) (1ORF-WT2). It consists of the pUC19 backbone
plus15 bp of the RmInt1 5′ exon from ISRm2011-2, the 1ORF
intron sequence and 5 bp of the 3′ exon followed by 145 bp of
the E. coli lacZ gene (positions 42–169). 1ORF is an engineered
ribozyme in which nucleotides 611–1759 of the large terminal
loop of the RmInt1 domain IV have been deleted (Costa et al.,
2006).
The construction of control donor (pKGEMA4) and recipient
(pJB0.6LAG) plasmids for in vivo retrohoming analysis has
been described elsewhere (Martínez-Abarca et al., 2004; Nisa-
Martínez et al., 2007). pKG4_MALFlagIEP was generated from
the pKGEMA4 donor plasmid by replacing the wild-type
IEP sequence with the MBP-FlagIEP fusion protein sequence.
The MBP-FlagIEP N-terminal region was amplified from
pMALFlagIEP with primers LMS33 5′-GGACTAGTGGAAAC
AGGATGAAAATCGAAGAAGG-3′ and PR1000 5′-GCGGAA
GATTGTCAAACAGC-3′ and Phusion polymerase (Thermo
Scientific). LMS33 hybridized to the start of the maltose-binding
protein sequence (the ATG start codon is shown in bold) and
included a SpeI restriction site (underlined), to facilitate cloning
in pKGEMA4. PR1000 is an oligonucleotide complementary
to positions 980–1000 in the wild-type RmInt1 sequence (454
bp into the IEP sequence) just downstream from the EcoRI
restriction site. pKGEMA4 was then digested with SpeI/EcoRI
and the fragment obtained was replaced with the corresponding
digested PCR product. The sequence of the insert was checked
before retrohoming assays.
Mobility Assays
We used a two-plasmid system based on a donor plasmid
(pKGEMA4-derived plasmids) encoding IEP followed by1ORF
and a recipient plasmid (pJB0.6LAG) containing a 640 bp
fragment of ISRm2011-2 including the DNA target site inserted
in the lagging strand orientation (Martínez-Abarca et al., 2000).
As negative controls, we used a splicing-deficient mutant intron
donor plasmid, pKG4dV, and a recipient plasmid lacking the
intron insertion site, pJB1129. Plasmid pools from S. meliloti
RMO17 were analyzed by Southern hybridization with probes
specific for the intron (ribozyme) and the target DNA (Martínez-
Abarca et al., 1998, 2000). Retrohoming efficiency was calculated
as a percentage relative to the wild-type intron, by determining
the proportion of the recipient plasmids invaded.
Expression and Purification of the
MBP-FlagIEP Fusion Protein in E. coli
E. coli Rosetta-gami (DE3) pLysS cells were freshly transformed
with the pMALFlagIEP expression plasmid or with a mutated
form of this plasmid. For starter cultures, a single colony was
used to inoculate 5 ml of LB medium containing antibiotics
and glucose, and the cultures were incubated overnight at
37◦C, with shaking at 270 rpm. An aliquot (1 ml) of the
overnight culture was then used to inoculate 50 ml of LB
medium + ampicillin + chloramphenicol + glucose, which
was incubated at 37◦C for 4 h with vigorous shaking, until
an OD600 of 0.5 was reached. Following IPTG induction, cells
were harvested by centrifugation at 5000 × g for 30 min
at 4◦C, and the pellet was washed twice with cold column
buffer (CB: 20 mM Tris-HCl pH 7.4, 200 mM NaCl, 1
mM EDTA, 1 mM DTT, EDTA-free protease inhibitor). The
cell pellet was resuspended in 1 ml of ice-cold CB buffer
and lysed by three freeze-thaw cycles (alternation between
−70◦C and +28◦C), followed by addition of 7 ml CB. Lysates
were subjected to sonication and cleared by centrifugation
(16,000 × g for 5 min at 4◦C). For protein binding to the
column (Econo-Pac Chromatography, Bio-Rad), which was
prepared with washed amylose beads (0.5 ml bead volume,
New England Biolabs), cleared lysates were incubated for 2
h at 4◦C on a rotary shaker. After washing to remove non-
specifically bound proteins, MBP-IEP was eluted by adding 2
ml CB supplemented with 10 mM maltose (Sigma-Aldrich).
Protein preparations were concentrated and dialyzed with YM-
30 centrifugal filters (Amicron Ultra, Millipore) Proteins were
analyzed by electrophoresis in Coomassie blue-stained 0.1%
SDS-10% polyacrylamide gels and immunoblot analysis with
antibodies against the Flag epitope (Sigma-Aldrich). Protein
concentrations were determined by the Bradford method, with
the Bio-Rad protein assay reagent and BSA as the standard
(Bio-Rad).
In vitro Transcription and Purification
pLMWT was linearized by using digestion with NdeI, for the
generation of a 908 nt RNA transcript. Unlabeled transcripts
were generated with 20 µg of linearized plasmid and 70 units
of T7 RNA polymerase in 1 ml reaction buffer containing
1× transcription buffer (10× transcription buffer: 150 mM
MgCl2, 400 mM Tris–HCl, pH 7.5, 20 mM spermidine, and
50 mM DTT), 0.96 mM NTPs, 10 mM DTT and 400 units
of RNAseOUT (Invitrogen). Internally labeled RNA transcripts
were generated with 4 µg of linearized plasmid, 1× transcription
buffer, 10 mMDTT, 0.96 mMATP, 0.96 mM CTP, 0.96 mMUTP,
0.064 mMGTP, 50 µCi [α-32P]GTP (3000 Ci/mmol; 10 mCi/mL;
Perkin Elmer), 80 units of RNAseOUT (Invitrogen) and 2–4 units
of T7 RNA polymerase, in a final volume of 50 µl (Chillón et al.,
2014). In both cases, RNA synthesis was stopped after 3–5 h
at 37◦C, by adding an equal volume of gel loading dye [10 M
urea, 0.1% (w/v) xylene cyanol and bromophenol blue dyes, 40
mMTris (pH 7.5), 8.3% (w/v) sucrose, and 0.83 mM EDTA].
RNA samples were subjected to electrophoresis in a 5% (w/v)
denaturing (7 M urea) polyacrylamide gel. The relevant bands
were excised and the RNA molecules were eluted by overnight
incubation in elution buffer (0.3 M NaCl, 10 mM MOPS pH 6,
1 mM EDTA). Residual polyacrylamide was removed and the
RNA was precipitated with ethanol and glycogen as the carrier.
The RNA was dried and dissolved in RNA storage buffer (10 mM
MOPS pH 6, 1 mM EDTA).
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Exogenous RT Assay
Reverse transcriptase with poly(rA)-oligo(dT)18 was carried out
as previously described (Muñoz-Adelantado et al., 2003). IEP
preparations (5 µM) were assayed in 10 µl of reaction medium
(50 mM Tris-HCl pH 7.5, 10 mM KCl, 25 mM MgCl2, 5 mM
DTT) with 1µg of poly(rA)-oligo(dT)18 or poly(rA), and 2.5µCi
of [α-32P]dTTP (800 Ci/mmole; Perkin Elmer). The products
(8 µl) were spotted onto Whatman DE81 filters, which were
then washed four times with 2 × SSC and counted in a liquid
scintillation analyzer (Beckman-Coulter).
Self-Splicing and IEP-Assisted Splicing
Protein-assisted splicing reactions were carried out with
internally 32P-labeled RNA and purified MBP-FlagIEP fusion
proteins. RNA precursor (1 nM) was incubated in 40 mM
Tris-HCl pH 7.5 at 90◦C for 1 min, then at 50◦C for 1
min and, finally, at room temperature for 1 min. Correct
RNA conformation/stabilization was favored by adding 500 mM
NH4Cl and 5 mM MgCl2 to the renatured samples. The splicing
reaction was triggered by the incorporation of a 50-fold excess of
the MBP-IEP fusion proteins and incubation of the mixtures at
30◦C. In vitro splicing control reactions from which the protein
was omitted were carried out at 50◦C for 5 h. Aliquots (1–2 µl)
were removed at the indicated timepoints and reactions were
stopped by the addition of 10 µl quenching buffer [1.8% sucrose,
1× TBE, 0.018% xylene cyanol dye, 36% (v/v) formamide, and
25 mM EDTA] and incubation on ice. The products were
resolved by electrophoresis in a denaturing 5% polyacrylamide
gel. The gel was then dried and the radioactivity quantified with
a Personal Molecular Imager FX (Bio-Rad) laser scanning system
and Quantity One software (Bio-Rad).
RNP Particle Reconstitution
RmInt1-1ORF RNP particles were reconstituted from
RNA synthesized in vitro and purified MBP-FlagIEP or the
corresponding mutated proteins, with a modified version of a
previously described method (Saldanha et al., 1999). Unlabeled
precursor intron RNA (2.5 µM) was denatured by heating at
90◦C for 1 min and then renatured by successive incubations at
50◦C and room temperature for 1 min each in 40 mM Tris-HCl
pH 7.5, before the addition of 500 mMNH4Cl, 5 mMMgCl2, and
5 µM purified MBP-FlagIEP protein. The mixture was placed
in a water bath at 30◦C for 30min to 2 h, and the samples were
then kept on ice. Freshly prepared reconstituted RNP particles
were used for RT and DNA endonuclease assays. Different
concentrations of RNA and protein were tested, to optimize the
protocol.
Primer Extension
RNP particle preparations were subjected to phenol extraction
and the RNA component was precipitated in ice-cold 100%
ethanol. Primer extension reactions were carried out essentially
as previously described (Molina-Sánchez et al., 2010). RNA
samples were resuspended in H2O and combined with 5
′-labeled
P primer (5′-TGAAAGCCGATCCCGGAG-3′) in 10 mM Pipes
(pH 7.5) and 400 mM NaCl. The annealing mixture was heated
at 85◦C for 5 min, rapidly cooled to 60◦C and slowly chilled
to 45◦C. Extension reactions were initiated by adding AMV RT
buffer 1x (5x: 250 mM Tris–HCl pH 8.0, 300 mM NaCl, 50 mM
DTT, 30 mM MgOAc), dNTPs, actinomycin D (Sigma-Aldrich),
RNase OUT (Invitrogen) and AMV RT (Roche Diagnostics)
and incubating at 42◦C for 60 min. The reactions were stopped
by ethanol precipitation and the products were subjected to
electrophoresis in a denaturing 6% polyacrylamide gel. Primer
extension products were quantified with Quantity One software
(Bio-Rad) and excision efficiency was determined as 100 ×
[Lariat/(Lariat+ Precursor)].
DNA Cleavage/Reverse Splicing Activity
DNA cleavage assays were carried out on a 70-mer single-
stranded DNA oligonucleotide containing the intron
insertion site at position 35, which was 5′ end-labeled
with [γ-32P]ATP (6000 Ci/mmol; Perkin-Elmer) and T4
polynucleotide kinase (New England Biolabs), or 3′ end-labeled
with terminal transferase (New England Biolabs) and cordycepin
5′-triphosphate [α-32P] 3′-deoxyadenosine (6000 Ci/mmol;
Perkin Elmer). DNA substrates were gel-purified and eluted
from acrylamide, essentially as previously described (Molina-
Sánchez et al., 2010). DNA oligonucleotide (300,000 cpm) was
incubated with reconstituted RNP particles (2.5 µl;∼900 nM) at
37◦C for 30 min to 2 h in reaction buffer (50 mM Tris-HCl pH
7.5, 10 mMKCl, 25 mMMgCl2, 5 mMDTT). The reactions were
cleaned by extraction with phenol-chloroform-isoamyl alcohol
(25:24:1) followed by ethanol precipitation, and the products
were analyzed by electrophoresis in denaturing 7 M urea-6%
(w/v) polyacrylamide gels. The gels were scanned and the
products were quantified with Quantity One software (Bio-Rad),
with the results expressed as a percentage of the activity of RNP
complexes reconstituted with the wild-type MBP-FlagIEP fusion
protein.
RESULTS AND DISCUSSION
In vivo Functionality of the MBP-FlagIEP
The IEPs of group II introns are proteins with a high proportion
of positively charged amino acids and an alkaline isoelectric
point, and their stability and solubility are, therefore, usually
low (Mohr et al., 2013; Zhao and Pyle, 2016). We overcame
these problems by producing the RmInt1 IEP as a fusion with
the maltose binding protein (pMAL, New England Biolabs). The
construct encoded the maltose binding protein (malE, MBP)
followed by the Flag epitope, all in-frame with the N-terminal
region of the RmInt1 intron ORF. We assessed the competence
of the MBP-FlagIEP fusion protein for assisting the in vivo
activities of RmInt1 intron RNA, by carrying out retrohoming
assays with a two-plasmid (donor/recipient) system (Martínez-
Abarca et al., 2004). We used an intron donor plasmid derived
from pKGEMA4 (Nisa-Martínez et al., 2007) and encoding the
fusion protein under the control of the kanamycin promoter
(PKm) and upstream from the RmInt1 1ORF ribozyme flanked
by exon sequences −20/+5 (Figure 1A). S. meliloti RMO17, an
intronless strain, harboring the recipient plasmid pJB0.6LAGwas
transformed with the pKG4_MALFlagIEP intron donor plasmid
(Figure 1B, lane 1). Homing efficiency was slightly lower (21%)
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FIGURE 1 | The MBP-FlagIEP fusion protein is functional in vivo. (A) The
scaled scheme shows the constructs used as intron donors. pKG4_MAL is a
derivative of pKGEMA4 in which the IEP has been replaced by the fusion
protein MBP-FlagIEP. PKm, kanamycin promoter; black arrows identify the IEP;
an open box flanked by gray lines corresponds to the intron 1ORF and short
−20/+5 exons, respectively. (B) A homing assay is shown in the upper panel.
The donor constructs indicated above were used to transform S. meliloti
RMO17, an intron-less strain, containing the recipient plasmid pJB0.6LAG.
The plasmid pools were analyzed by Southern hybridization with a DNA intron
probe. An intron donor plasmid harboring a mutation in the catalytic domain of
the ribozyme (pKG4dV) or a recipient plasmid lacking the recognition DNA
target region (pJB1129) was used as a control. The lower panel corresponds
to quantification of the retrohoming efficiency expressed as a percentage
relative to that for the pKGEMA4 construct. The data shown are the means for
at least three independent colonies ± standard errors.
than for the wild-type protein construct, pKGEMA4 (lane 2). The
MBP-IEP fusion protein therefore seemed to be fully functional
in vivo.
Production, Purification, and RT Activity of
the RmInt1 IEP
The MBP-FlagIEP cassette was inserted downstream from the
tac promoter and the fusion protein was produced in Rosetta-
Gami (DE3) pLysS cells after IPTG induction. The protein
was purified further by affinity chromatography on amylose
resin (see Materials and Methods). The one-step purification
procedure yielded large amounts of soluble protein (1–60 mg/L
of culture), but the preparation was heterogeneous, containing
protein aggregates and partially degraded/synthesized protein
fragments (not shown). Quantification of the various bands
FIGURE 2 | Purified MBP-FlagIEP has reverse transcriptase activity in
vitro. (A) The bar graphs show the reverse transcriptase activity of the
MBP-FlagIEP fusion assayed with poly(rA)/oligo(dT)18 (black bar), or with
poly(rA) [in the absence of oligo(dT)18, white bar]. The RT activity is expressed
in counts per minute (cpm). The data shown are the means for at least three
independent assays and three to seven independent MBP-FlagIEP
preparations. Error bars represent the standard errors. (B) The RT activity of
several mutant proteins was evaluated relative to the wild-type fusion protein.
Note that the Y axis is represented in logarithmic scale. RT values were
derived from at least three experimental replicates, with three different protein
preparations used for each mutant. Error bars correspond to the standard
errors.
suggested that the full-length protein preparation was about 70%
pure (checked for several different preparations).
We assessed the functionality of the protein, by carrying
out reverse transcriptase assays with the exogenous substrate
poly(rA)/oligo(dT)18 (Figure 2A). The MBP-FlagIEP fusion
protein displayed significant RT activity in the presence of the
RNA substrate and the DNA primer (8.6 × 105 cpm), whereas
the absence of oligo(dT)18 resulted in much lower levels of cDNA
synthesis (2 × 103 cpm). As a control, we also investigated
three other fusion proteins in which conserved residues of the
RT and maturase domains had been mutated (Figure 2B). As
expected, cDNA synthesis was abolished in the RT-deficient
YAHHmutant (0.3% wild-type), in which two essential aspartate
residues in RT domain 5 were replaced with histidines (Muñoz-
Adelantado et al., 2003). The YYAA maturase-null mutant, in
which two conserved tyrosine residues at positions 354–355 in
the RGWXNYY maturase motif were replaced with two alanine
residues, had very low levels of RT activity (1.7% wild-type). In
addition, the K381A mutant, with a substitution of the lysine 381
residue in the conserved maturase R(K/R)XK motif decreasing
intron excision rates to 30% those for the wild type (Molina-
Sánchez et al., 2006, 2010), had low levels of RT activity (22%
wild-type). These results suggest that these residues might be
relevant for the substrate docking required for cDNA synthesis,
to somewhat different degrees. Thus, MBP-FlagIEP was stable
and active when assayed alone in the absence of the intron RNA.
RmInt1 Splicing In vitro
As the fusion protein itself has RT activity, we investigated
whether this protein could interact successfully with the intron
ribozyme. Previous studies performed by our group revealed
that RmInt1 efficiently self-spliced in vitro in the presence of
high-magnesium (100 mM) buffer, but that these conditions
gave rise to multiple products corresponding in size to the lariat
intron-3′exon intermediate, and lariat or circle (double band)
introns (Costa et al., 2006; Chillón et al., 2014). IEP-promoted
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splicing of a 906 nt 1ORF precursor RNA was monitored over
time (Figure 3). Protein-assisted splicing of the 1ORF RNA
precursor resulted in a single lariat RNA product (Figure 3A).
A two-exponential model fitted the data well, with an initial fast
reaction (>60% of lariat formation was completed in the first
15 min) followed by a phase of slow reactivity (Figure 3B). In
the presence of MBP-FlagIEP wild-type, the percentage lariat
formation reached 31%. IEP-promoted in vitro splicing was
performed in different Mg2+ concentrations, but the results
were not improved by increasing MgCl2 concentration beyond
5 mM (not shown). As previously reported, this low-magnesium
buffer does not allow intron excision in the absence of the IEP
(Figure 3, left panel). Hence, IEP assistance reduces magnesium
requirements and accelerates lariat formation, preventing the
production of secondary products. A two-phase reaction has
also been reported for LtrA-assisted splicing, with a fast phase
in which about 50–75% of the molecules react, followed by a
slow reaction until the fraction spliced finally reaches 75–95%,
depending on the conditions (Wank et al., 1999; Matsuura et al.,
2001; Noah and Lambowitz, 2003; Cui et al., 2004).
We also evaluated the ability of mutant proteins to assist the
splicing of the intron RNA. Consistent with our in vivo results
(Molina-Sánchez et al., 2010), there was no significant difference
in lariat formation between the YAHH mutant and the wild-
type MBP-FlagIEP (Figure 3). Likewise, the splicing-deficient
YYAA mutant was unable to induce intron excision in vitro,
and substitution of the K381 residue greatly decreased splicing
efficiency (20% wild-type levels). Our results therefore indicate
that the catalytic residues for RT are not directly involved in
RmInt1 splicing, and are consistent with a possible alteration
of the domain X mutant IEPs protein structure and binding
properties.
Together, these results indicate that the MBP-FlagIEP fusion
protein functionally complements the ribozyme activity of the
RmInt1 intron and is therefore suitable for use in RNP particle
reconstitution in vitro.
Reconstituted RNP Particles Have DNA
Endonuclease Activity
We investigated whether the IEP and the excised lariat RNA
were sufficient for RmInt1 DNA endonuclease activity, by
reconstituting RNP particles from the components purified in
vitro, as previously described by Saldanha et al. (1999). The
1ORF precursor RNA was incubated with MBP-FlagIEP, in
different ratios, at 30◦C for 30–60 min. These experiments
assessed the ability of the protein to promote RmInt1 RNA
splicing, assuming that the complex remained intact to generate
active RNP particles containing the protein and the intron
lariat. We tested this hypothesis, by evaluating lariat formation
by primer extension (Figure 4A). The cDNA was synthesized
with an intron-specific primer complementary to a sequence
located 80–97 nucleotides from the 5′ end of the intron
(Muñoz-Adelantado et al., 2003). The unspliced precursor-
derived products were detected as a 112 nt band, whereas the
cDNA corresponding to the lariat molecules migrated at 97 nt. As
expected, the amount of lariat formed increased with the amount
FIGURE 3 | RmInt1 splicing efficiency in vitro. (A) The left panel (lanes
1–2) shows the inability of RmInt1 to self-splice in vitro. Splicing reactions were
carried out by incubating 32P-labeled, 905 nt RmInt1 1ORF RNA with 5 mM
MgCl2 for 0 and 300 min. The panels on the right (lanes 3–18) show RmInt1
IEP-assisted splicing, as evaluated by incubating a 32P-labeled 1ORF RNA
precursor with different protein preparations in a buffer containing 5 mM
MgCl2 for various times. The radioactively labeled precursor 1ORF RNA was
incubated with a 50-fold excess of wild- type MBP-FlagIEP fusion protein
(middle panel) or RmInt1 IEP mutant proteins (right panel) for 0, 5, 30, and 120
min. The arrows on the right indicate the products obtained: La, fully spliced
lariat RNA; and, Pre, precursor RmInt1 1ORF RNA. (B) Kinetic data, including
additional time points, are plotted as the percentage lariat formation relative to
the level of precursor RNA. Lines in black/squares represent the MBP-FlagIEP
wild-type fusion protein; the RT-deficient mutant (MBP-FlagYAHH) is indicated
by a broken black line/triangles; maturase domain mutants are indicated with a
solid gray line/circles (MBP-FlagA354A355) or a broken line/diamonds
(MBP-FlagA381). The experiment was repeated twice, with at least two
independent purified fusion proteins for each mutant.
of MBP-FlagIEP added, before reaching a plateau at about 30%
lariat (ratio RNA:IEP 1:50), with no further increase even if
the amount of protein was doubled. This finding is consistent
with those for our IEP-assisted splicing experiments (Figure 3),
suggesting that considerable large proportion of intron RNA
cannot take part in the reaction.
We assessed the best conditions for RNP particle
reconstitution, by carrying out DNA endonuclease assays
with titrated reconstitution reactions (Figure 4B). In DNA
endonuclease experiments, we incubated reconstituted RNP
particles with a 5′ end-labeled 70 nt single-stranded DNA
substrate containing the intron recognition site located at
position 35. We found that adding the intron RNA or the fusion
protein alone did not generate a cleavage band (lanes 2 and 3).
Incubation of the substrate with RNP particles reconstituted
with a fixed amount of RNA (2 pmol) and increasing amounts of
MBP-FlagIEP revealed that cleavage efficiency increased with the
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FIGURE 4 | Reconstitution of RNP particles with the MBP-FlagIEP
fusion protein and in vitro-synthesized intron RNA. (A) Lariat formation
during the RmInt1 RNP particles reconstitution process was estimated by
primer extension. RNP particles reconstituted with different ratios of 1ORF
RNA precursor and MBP-FlagIEP fusion protein were subjected to phenol
extraction and used as the template for reverse transcription reactions with an
intron-specific primer. The intron lariat gave rise to a 97 nt cDNA, whereas the
RNA precursor generated a 112 nt product. In vitro-transcribed RNAs
corresponding to the precursor and lariat RNA molecules were used as
controls. The percentage lariat formation is plotted below. Results were verified
by analyses of at least three different IEP preparations and are presented as
the mean ± standard error. (B) DNA endonuclease activity on 32P-labeled
single stranded DNA substrates (70 nt). DNA cleavage activity resulted in a 35
nt product. The control samples are shown in the left panel: neither RNA nor
MBP-FlagIEP, only RNA precursor, only MBP-FlagIEP, and RNA precursor with
a domain V mutation (*) plus MBP-FlagIEP. In the middle panel, the DNA
substrate was incubated with RNP particles reconstituted from a constant
amount of RNA precursor (2 pmol) and increasing amounts of MBP-FlagIEP
(10, 25, and 50 pmol). In the right panel, the DNA substrate was incubated
with RNP particles reconstituted from a fixed amount of MBP-FlagIEP (100
pmol) and increasing amounts of 1ORF RNA precursor incubated with the
ssDNA target substrate. (C) Cleavage efficiency for 70 nt single-stranded DNA
substrates 32P-labeled at the 5′ and 3′ ends, with RNP particles reconstituted
from 5 µM wild-type to mutant IEPs and 2.5 µM 1ORF precursor RNA,
determined after 2 h of incubation. The molecules resulting from the DNA
endonuclease reaction are indicated on the right (not drawn to scale): The
white box represents the 5′ exon and the black rectangle corresponds to the
3′ exon; the black line identifies the intron RNA.
amount of protein used for reconstitution, probably reflecting
the active RNP complex levels (lanes 5–7). Likewise, for RNP
particles reconstituted with a constant amount of MBP-FlagIEP
(100 pmol) but increasing amounts of precursor RNA, cleavage
product levels increased with the amount of precursor RNA,
reflecting higher levels of active RNP particle formation (lanes
8–10). No DNA endonuclease activity was detected when the
RNP particles were reconstituted with a precursor RNA with
a mutated domain V (GUU→CGA) resulting in a loss of
splicing ability (lane 4). Suitable conditions for RNP particle
reconstitution would therefore be a 1:2 ratio of RNA to IEP and
2.5 µM intron RNA. Higher concentrations of RNA did not
increase the efficiency of the reaction, with DNA endonuclease
activity eventually becoming saturated. These data are consistent
with previous findings for LtrA, for which kinetic analyses
of splicing and RNA binding reactions showed that the LtrA
protein bound to Ll.LtrB RNA as a dimer (Saldanha et al., 1999;
Wank et al., 1999; Rambo and Doudna, 2004). However, this
interpretation should be viewed with caution, because it conflicts
with findings for RNP complex stoichiometry based on recent
structural determinations (Gupta et al., 2014; Qu et al., 2016;
Zhao and Pyle, 2016).
Having established appropriate reaction conditions, we
investigated whether the RNP particles reconstituted with
different mutant proteins were active in DNA cleavage. The
wild-type fusion protein cleaved the substrate, generating a 35
nt product corresponding to the intron insertion site that was
more clearly visible when the substrate was labeled at the 5′
end (Figure 4C, lane 1) than when it was labeled at the 3′
end (lane 2). The presence of high-molecular weight bands in
lanes containing 5′ end-labeled substrates would correspond to
full reverse-splicing products. On the contrary, 3′ end-labeled
substrates might reveal both full and partial reverse splicing.
We observed partial reverse splicing products with wild-type
reconstituted RNP particles (lane 2), but we cannot rule out
that full reverse splicing occurs. These data correlate with those
obtained for other group II introns, that shown significantly
more partial reverse splicing than full reverse splicing (Matsuura
et al., 1997; Saldanha et al., 1999; Aizawa et al., 2003). Similar
results were obtained with RNP complexes reconstituted with
the MBP-YAHH RT-deficient mutant, which displayed high
levels of DNA cleavage activity (90–95% of wild-type, lane 3).
By contrast, as expected reconstituted RNP particles using
the MBP-YYAA mutant protein were unable to cleave the
DNA substrate at the insertion site, resulting in the absence
of reverse splicing bands (lanes 5–6). Finally, RNP particles
reconstituted with the K381A mutant protein had lower levels
of cleavage activity than wild-type complexes (78%; lane 7),
consistent with the lower RT and splicing activities observed,
and only bands generated by partial reverse splicing were also
detected (lane 8). These findings may explain why this mutant
has no retrohoming activity in vivo (Molina-Sánchez et al.,
2010).
CONCLUDING REMARKS
In this work, we developed a protocol for producing active
RmInt1 IEP. The MBP-Flag IEP fusion protein was competent
for reverse transcription and facilitated intron splicing in vitro,
reducing Mg2+ requirements. Like other group II introns,
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RmInt1 IEP-dependent splicing occurred in a two-phase
reaction: most of the lariat molecules were generated rapidly,
early in the incubation period, and there was then a slow reaction
phase. We were also able to produce RNP particles in vitro from
the two purified components, and these complexes efficiently
cleaved single-stranded DNA substrates, with the intron RNA
mostly remaining linked to the 3′ exon. We also obtained control
RNP particles, which reproduced in vitro the activities previously
described for RNP-enriched fractions recovered in vivo (Molina-
Sánchez et al., 2010).
RNP particles formed in vivo have already been purified
with tagging and other similar procedures (Zerbato et al.,
2013; Qu et al., 2016), but, to our knowledge, there have
been only two reports of active RNP complex reconstitution in
vitro from purified components (Ll.ltrB, Saldanha et al., 1999
and subsequent studies arising from this work; and, B.h.I1,
Robart et al., 2007). Further studies increasing our insight,
the efficiency of RNP particle reconstitution and the purity of
RNP particle preparations will provide tools for exploring new
biotechnological applications for group II introns lacking the
DNA endonuclease domain.
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